Certified by Founder Lodge
Casdin Capital, LLC
United States - New York, New York
INVESTOR
1 Disclosed Funding Rounds $200,000,000
15 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Casdin Capital, LLC is a New York-based research investment firm focused on the innovations in molecular medicine currently reshaping Life Sciences and healthcare. Founded in 2011, and with a
Company | Date | Round | Raised |
---|---|---|---|
Octave (US) | July, 27 ,2023 | Series B | $30,000,000 |
Asimov | January, 09 ,2023 | Series B | $200,000,000 |
IDRx | August, 02 ,2022 | Series A | $122,000,000 |
Remix Therapeutics | January, 04 ,2024 | Unknown | $60,000,000 |
Arzeda | April, 04 ,2022 | Series B | $33,000,000 |
Scorpion Therapeutics | July, 17 ,2024 | Series C | $150,000,000 |
Flare Therapeutics | March, 23 ,2023 | Series B | $123,000,000 |
TMRW Life Sciences | July, 25 ,2024 | Series D | $28,000,000 |
Function Oncology | April, 13 ,2023 | Series A | $28,000,000 |
Orbital Therapeutics | April, 27 ,2023 | Series A | $270,000,000 |
Septerna | July, 18 ,2023 | Series B | $150,000,000 |
Octave (US) | July, 27 ,2023 | Series B | $30,000,000 |
Remix Therapeutics | January, 04 ,2024 | Unknown | $60,000,000 |
Scorpion Therapeutics | July, 17 ,2024 | Series C | $150,000,000 |
TMRW Life Sciences | July, 25 ,2024 | Series D | $28,000,000 |